IQV News and Press, IQVIA Holdings Inc. From 04/15/24

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release a...

2024-04-13 10:52:04 ET More on AbbVie, Amgen, etc. AbbVie: Bulletproof Fundamentals AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67% UnitedHealth Q1 2024 Earnings Preview: Headwinds Not Enough To Derail This Juggernaut GLP-1s benefit Park...

2024-04-10 13:49:47 ET More on Technology Select Sector SPDR ETF: XLK: It's Tech's Time To Shine Again XLK May Still Have Fuel For Growth XLK: Ring The Cash Register, It's Starting To Get Overvalued Global Stock leaders for 2030 in Fin Tech - UBS Glob...

2024-04-10 02:20:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

2024-04-08 16:14:25 ET More on Salesforce, IQVIA, etc. Salesforce: Too Far, Too Fast (Rating Downgrade) Salesforce: Currently Overvalued And It Requires A Lot To Revert It (Downgrading To Hold) Salesforce: When A Drastic Shift In Strategy Serves Shareholders' Interes...

IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce (NYSE:CRM), the #1 AI CRM, today announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a nex...

2024-04-05 08:30:53 ET More on AbbVie AbbVie Inc. (ABBV) Barclays 26th Annual Global Healthcare Conference (Transcript) AbbVie: Comeback Expected After Humira Patent Expiration AbbVie Stock: I Was So Wrong, But This Is Way Too Fast AbbVie slips after revising...

2024-03-24 21:53:59 ET Summary Harris Associates' 13F portfolio value increased from $51.39B to $58.34B in Q4 2023. The portfolio is diversified with around 200 positions, with the largest five stakes being Alphabet, Capital One Financial, IQVIA, Intercontinental Exchange, and Cha...

2024-03-23 14:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-16 12:57:30 ET More on Madrigal Pharmaceuticals Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Ra...